Your browser doesn't support javascript.
loading
New Generation of Selective Androgen Receptor Degraders: Our Initial Design, Synthesis, and Biological Evaluation of New Compounds with Enzalutamide-Resistant Prostate Cancer Activity.
Hwang, Dong-Jin; He, Yali; Ponnusamy, Suriyan; Mohler, Michael L; Thiyagarajan, Thirumagal; McEwan, Iain J; Narayanan, Ramesh; Miller, Duane D.
Afiliação
  • Hwang DJ; Department of Pharmaceutical Sciences , University of Tennessee Health Science Center , Memphis , Tennessee 38163 , United States.
  • He Y; Department of Pharmaceutical Sciences , University of Tennessee Health Science Center , Memphis , Tennessee 38163 , United States.
  • Ponnusamy S; Department of Medicine , University of Tennessee Health Science Center , Memphis , Tennessee 38163 , United States.
  • Mohler ML; Department of Pharmaceutical Sciences , University of Tennessee Health Science Center , Memphis , Tennessee 38163 , United States.
  • Thiyagarajan T; GTx, Inc. , Memphis , Tennessee 38103 , United States.
  • McEwan IJ; Department of Medicine , University of Tennessee Health Science Center , Memphis , Tennessee 38163 , United States.
  • Narayanan R; School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences , University of Aberdeen , Aberdeen AB25 2ZD , Scotland , U.K.
  • Miller DD; Department of Medicine , University of Tennessee Health Science Center , Memphis , Tennessee 38163 , United States.
J Med Chem ; 62(2): 491-511, 2019 01 24.
Article em En | MEDLINE | ID: mdl-30525603

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Receptores Androgênicos / Resistencia a Medicamentos Antineoplásicos / Amidas Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Desenho de Fármacos / Receptores Androgênicos / Resistencia a Medicamentos Antineoplásicos / Amidas Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article